NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$9.42
Tradestie Score
48
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+48.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.40
|
$1.63B | - | 52 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.71
|
$1.57B | - | 48 | Compare |
|
VCEL
Vericel Corporation
|
$38.34
|
$1.56B | 80.6 | 51 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.20
|
$1.55B | - | 52 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$41.52
|
$1.55B | 13.5 | 46 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$38.02
|
$1.55B | - | 52 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.10
|
$1.50B | 7.1 | 53 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.66
|
$1.50B | - | 41 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$31.62
|
$1.49B | - | 40 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$24.59
|
$1.43B | - | 42 | Compare |
More NVAX Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry